Cover Image

Survey of off-label anti-IL1 treatments in France: preliminary data

Saved in:

Bibliographic Details
Main Authors:	Koné-Paut I (Author), Fautrel B (Author), Galeotti C (Author), Rossi-Semerano L (Author)
Format:	Book
Published:	BMC, 2011-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is Still's Disease an Autoinflammatory Syndrome?
by: Linda Rossi-Semerano, et al.
Published: (2012)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
by: Hachulla E, et al.
Published: (2011)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
by: Koné-Paut I, et al.
Published: (2011)

List of diseases with off-label treatment
by: article Editorial
Published: (2022)

Off-label use of oncology drugs: national survey results
by: Eva González-Haba Peña, et al.
Published: (2015)

The knowledge and experience with the off-label use - results of a survey
by: Maria Drenska, et al.
Published: (2019)

Editorial: Pathogenesis, Clinical Findings, and Treatment Advances in Kawasaki Disease
by: Teresa Giani, et al.
Published: (2021)

Analysis of primary outpatient data for off-label use of medicines in neurology
by: Maria Drenska, et al.
Published: (2019)

Off-label drug in the newborn
by: Laura Cuzzolin
Published: (2014)

Subtype-Specific Off-Label Treatment of Rosacea
by: Nita Wienholtz, et al.
Published: (2021)

The problem of off label drug use in pediatrics: pediatricians and parents survey results
by: E. A. Mardganieva, et al.
Published: (2018)

Biologics in dermatology: Off-label indications
by: Debdeep Mitra, et al.
Published: (2020)

Off-label uses of retinoids in dermatology
by: Wei Li, et al.
Published: (2012)

Challenges on off label medicine use
by: Marisa Lima Carvalho
Published: (2016)

PRESCRIÇÃO DE MEDICAMENTOS OFF-LABEL
by: Ana Escoval, et al.
Published: (2011)

Off-label prescription of drugs at hospital
by: Vicente Arocas Casañ, et al.
Published: (2016)

The journey of canakinumab; on- and off-label indications
by: Daniela Marotto, et al.
Published: (2019)

Off-label pediatric medicines in Spain
by: Roi Piñeiro Pérez, et al.
Published: (2021)

Off-label and unlicensed drugs in neonatology
by: Segundo Rite-Gracia, et al.
Published: (2021)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
by: Weilan Wang, et al.
Published: (2013)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China.
by: Weilan Wang, et al.
Published: (2013)

Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic
by: Haulrig MB, et al.
Published: (2021)

Off-label use of rituximab in dermatology: pemphigus treatment
by: Lislaine Bomm, et al.
Published: (2013)

Massive presence of off‐label medicines in Danish neonatal departments: A nationwide survey using national hospital purchase data
by: Christina Gade, et al.
Published: (2023)

Hypofertility in Muckle Wells syndrome and treatment with IL-1 targeting drugs
by: Tran Tu-Anh, et al.
Published: (2011)

Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population
by: Stella Pesiou, et al.
Published: (2024)

A Survey of Off-label and Unlicensed Antibiotic and Respiratory Medications Prescribed for Toddler Patients
by: Ali Soochi, et al.
Published: (2022)

Uso off label: erro ou necessidade?

Uso off label: erro ou necessidade?
Published: (2012)

Drug use in off-label dosage regimes
by: Roberto Lozano Ortiz
Published: (2015)

"Off-Label" use of antibiotics in critical patients
by: Cristina Mihaela Ghiciuc, et al.
Published: (2022)

On- and off-label use of rituximab in rheumatic diseases
by: Gilda Sandri, et al.
Published: (2021)

Evaluating the Use of Dalbavancin for Off-Label Indications
by: Katherine Taylor, et al.
Published: (2022)

Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System
by: Annamaria Mascolo, et al.
Published: (2020)

Intravenous immunoglobulin therapy among pediatric patients: labeled and off-labeled indications
by: Chin Chiang Toh, et al.
Published: (2018)

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015)

Topical Sirolimus 0.1% as Off Label Treatment of Kaposi's Sarcoma
by: Vittorio Tancredi, et al.
Published: (2024)

Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab
by: Zhiyu Zhang, et al.
Published: (2023)

Unsupported off-label chemotherapy in metastatic colon cancer
by: de Souza Jonas A, et al.
Published: (2012)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
by: Min Meng, et al.
Published: (2022)